H19 and neoplasm: Meanwhile, no significant differences (p > 0.05) were identified between the RNA m5C modification of H19 and other clinicopathological characteristics, including patient age, sex, extrahepatic metastasis, liver cirrhosis, and tumor size (Table 1 and Table 2).